NRC
NASDAQ · Health Care
National Research Corp
$15.94
+0.01 (+0.06%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 183.35M | 186.15M | 191.25M |
| Net Income | 19.67M | 14.97M | 19.17M |
| EPS | — | — | — |
| Profit Margin | 10.7% | 8.0% | 10.0% |
| Rev Growth | +17.3% | -4.1% | -8.3% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 20.28M | 19.99M | 16.96M |
| Total Equity | 254.17M | 255.25M | 239.89M |
| D/E Ratio | 0.08 | 0.08 | 0.07 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 22.93M | 21.30M | 22.66M |
| Free Cash Flow | 12.72M | 13.38M | 16.98M |